Senators are demanding to know why Novo Nordisk discontinued Levemir, one of the nation's three long-acting insulins.
In an April 16 letter, New Hampshire Sen. Jeanne Shaheen, Georgia Sen. Raphael Warnock and Massachusetts Sen. Elizabeth Warren asked the Denmark-based drugmaker why Levemir was removed from the U.S. market.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,